Wednesday, July 8, 2026
🇺🇸 FDA

Intelligence · INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Recently updated

FDA-approved

Showing page 1 of 200 · By data quality, then INN

  1. abacavir sulfate

    ABACAVIR SULFATE Teva Pharma GmbH

    ORAL FDA: approved

  2. abiraterone acetate

    ABIRATERONE KRKA Amneal Pharma Europe Ltd

    ORAL FDA: approved · EMA: approved

    L02BX03

  3. acamprosate calcium

    ACAMPROSATE CALCIUM Teva Pharma GmbH

    ORAL FDA: approved

  4. acebutolol hydrochloride

    ACEBUTOLOL HYDROCHLORIDE Amneal Pharma Europe Ltd

    ORAL FDA: approved

  5. aceclidine hydrochloride

    VIZZ LENZ Therapeutics

    OPHTHALMIC FDA: approved

  6. acetaminophen

    ACEPHEN Teva Pharma GmbH

    RECTAL FDA: approved · NMPA: clinical trials

  7. acetazolamide

    DIAMOX Lacuna Pharma Pty Ltd

    ORAL FDA: approved · TGA: approved

  8. acetazolamide sodium

    ACETAZOLAMIDE SODIUM Teva Pharma GmbH

    INJECTION FDA: approved

  9. acetohexamide

    DYMELOR Teva Pharma GmbH

    ORAL FDA: approved

  10. acetylcysteine

    ACETYLCYSTEINE Regeneron Ireland Designated Activity Company (DAC)

    ORAL FDA: approved

  11. acitretin

    NEOTIGASON Lacuna Pharma Pty Ltd

    ORAL FDA: approved · TGA: approved

  12. acoramidis hydrochloride

    BEYONTTRA BridgeBio Oncology Therapeutics

    ORAL FDA: approved · PMDA: approved

  13. acyclovir

    ZOVIRAX Amneal Pharma Europe Ltd

    OPHTHALMIC FDA: approved

  14. acyclovir sodium

    ACYCLOVIR SODIUM Teva Pharma GmbH

    INJECTION FDA: approved

  15. adalimumab-aqvh

    YUSIMRY Coherus Oncology

    INJECTION FDA: approved

  16. adenosine

    ADENOSINE Regeneron Ireland Designated Activity Company (DAC)

    INJECTION FDA: approved

  17. adenovirus-mediated herpes simplex virus-thymidine kinase gene

    CEREPRO Ark Therapeutics

    EMA: application withdrawn

  18. aflibercept

    AFQLIR Bayer Australia Ltd

    INJECTION FDA: approved · EMA: approved · TGA: approved · PMDA: approved

    S01LA05

  19. agalsidase alfa

    REPLAGAL Takeda

    EMA: approved

    A16AB03

  20. albuterol

    AIROMIR AUTOHALER GlaxoSmithKline

    INHALATION FDA: approved · TGA: approved

  21. albuterol sulfate

    PROVENTIL Amneal Pharma Europe Ltd

    INHALATION FDA: approved

  22. alendronate sodium

    ALENDRONATE SODIUM Teva Pharma GmbH

    ORAL FDA: approved

  23. alirocumab

    PRALUENT Regeneron UK Limited

    INJECTION FDA: approved · EMA: approved · PMDA: approved · NMPA: clinical trials

    C10AX14

  24. aliskiren

    RASILEZ Lxo Ireland Designated Activity Company

    EMA: approved

    C09XA02

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.